JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reis, D. J.
Right arrow Articles by Ross, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reis, D. J.
Right arrow Articles by Ross, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*RESERPINE

Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-beta-hydroxylase in catecholamine neuronal systems in rat brain

DJ Reis, TH Joh and RA Ross

Reserpine (10 mg/kp i.p.) increased the activities of the enzymes tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase, but not dopa decarboxylase, 2- to 3-fold in the nucleus locus ceruleus of rat brain. The TH response was dose-dependent, reached a maximum by 48 hours and recovered by 3 weeks. The increased activities of TH and dopamine-beta- hydroylase were shown by immunotitration with specific antibodies to each enzyme to be due entirely to increased accumulation of specific enzyme protein. At a time when the reserpine-elicited accumulation of TH was increased 300% in the locus ceruleus, activity of the enzyme only increased 20% in hypothalamus and not at all in substantia nigra or caudate nucleus. Reserpine increased the accumulation of TH, primarily in the cell bodies and to a far less degree in the terminals of neurons of locus ceruleus but not in dopaminergic neurons of the nigrostriatal system. The time course of enzyme accumulation parallels that of depletion of monoamines in brain.

Volume 193, Issue 3, pp. 775-784, 06/01/1975
Copyright © 1975 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
J. R. Prohaska and B. Brokate
Dietary Copper Deficiency Alters Protein Levels of Rat Dopamine {beta}-Monooxygenase and Tyrosine Monooxygenase
Experimental Biology and Medicine, March 1, 2001; 226(3): 199 - 207.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
J. R. Prohaska and B. Brokate
Copper Deficiency Alters Rat Dopamine {beta}-Monooxygenase mRNA and Activity
J. Nutr., December 1, 1999; 129(12): 2147 - 2153.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C.-H. Kim, H.-S. Kim, J. F. Cubells, and K.-S. Kim
A Previously Undescribed Intron and Extensive 5' Upstream Sequence, but Not Phox2a-mediated Transactivation, Are Necessary for High Level Cell Type-specific Expression of the Human Norepinephrine Transporter Gene
J. Biol. Chem., March 5, 1999; 274(10): 6507 - 6518.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
T.H. Joh, E.E. Baetge, M.E. Ross, and D.J. Reis
Evidence for the Existence of Homologous Gene Coding Regions for the Catecholamine Biosynthetic Enzymes
Cold Spring Harb Symp Quant Biol, January 1, 1983; 48(0): 327 - 335.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics.